[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HUP0000233A3 - Use of pyrazolinone derivatives for producing pharmaceutical compositions useful for treating disturbances of potency - Google Patents

Use of pyrazolinone derivatives for producing pharmaceutical compositions useful for treating disturbances of potency

Info

Publication number
HUP0000233A3
HUP0000233A3 HU0000233A HUP0000233A HUP0000233A3 HU P0000233 A3 HUP0000233 A3 HU P0000233A3 HU 0000233 A HU0000233 A HU 0000233A HU P0000233 A HUP0000233 A HU P0000233A HU P0000233 A3 HUP0000233 A3 HU P0000233A3
Authority
HU
Hungary
Prior art keywords
potency
pharmaceutical compositions
compositions useful
producing pharmaceutical
treating disturbances
Prior art date
Application number
HU0000233A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HUP0000233A2 publication Critical patent/HUP0000233A2/hu
Publication of HUP0000233A3 publication Critical patent/HUP0000233A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU0000233A 1996-10-14 1997-10-08 Use of pyrazolinone derivatives for producing pharmaceutical compositions useful for treating disturbances of potency HUP0000233A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19642284A DE19642284A1 (de) 1996-10-14 1996-10-14 Pyrazolinone zur Behandlung von Potenzstörungen
PCT/EP1997/005532 WO1998016224A1 (de) 1996-10-14 1997-10-08 Pyrazolinone zur behandlung von potenzstörungen

Publications (2)

Publication Number Publication Date
HUP0000233A2 HUP0000233A2 (hu) 2001-04-28
HUP0000233A3 true HUP0000233A3 (en) 2001-06-28

Family

ID=7808669

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000233A HUP0000233A3 (en) 1996-10-14 1997-10-08 Use of pyrazolinone derivatives for producing pharmaceutical compositions useful for treating disturbances of potency

Country Status (14)

Country Link
EP (1) EP0930881A1 (hu)
JP (1) JP2001501958A (hu)
KR (1) KR20000049086A (hu)
CN (1) CN1233178A (hu)
AR (1) AR008494A1 (hu)
AU (1) AU4945297A (hu)
BR (1) BR9712307A (hu)
CA (1) CA2268823A1 (hu)
DE (1) DE19642284A1 (hu)
HU (1) HUP0000233A3 (hu)
NO (1) NO991734L (hu)
PL (1) PL332821A1 (hu)
WO (1) WO1998016224A1 (hu)
ZA (1) ZA979151B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410584B1 (en) 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6875575B1 (en) 1998-11-25 2005-04-05 Osi Pharmaceuticals, Inc. Diagnostic methods for neoplasia
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
DE19518082A1 (de) * 1995-05-17 1996-11-21 Merck Patent Gmbh 4(-Arylaminomethylen)-2,4-dihydropyrazol-3-one

Also Published As

Publication number Publication date
KR20000049086A (ko) 2000-07-25
CN1233178A (zh) 1999-10-27
ZA979151B (en) 1998-05-11
HUP0000233A2 (hu) 2001-04-28
NO991734D0 (no) 1999-04-13
WO1998016224A1 (de) 1998-04-23
EP0930881A1 (de) 1999-07-28
PL332821A1 (en) 1999-10-11
NO991734L (no) 1999-04-13
DE19642284A1 (de) 1998-04-16
AR008494A1 (es) 2000-01-19
CA2268823A1 (en) 1998-04-23
JP2001501958A (ja) 2001-02-13
BR9712307A (pt) 1999-08-31
AU4945297A (en) 1998-05-11

Similar Documents

Publication Publication Date Title
HUP0001267A3 (en) Use of rapamycin derivatives for the preparation of pharmaceutical compositions treating vasculopathies
IL125404A0 (en) 4-amino-pyrimidine derivatives medicaments containing these compounds their use and process for their production
HUP9901086A3 (en) Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
AP9901556A0 (en) Sulpponamide derivatives process for their preparation and their use as medicaments
HUP0001607A3 (en) Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds
HUP9802300A3 (en) N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUT56565A (en) Process for producing 3-arylcarbonyl-1h-indole derivatives and pharmaceutical compositions comprising same
HUP0000323A3 (en) N-substituted 2-cyanopyrrolidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9700126A3 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazotidinone derivatives and pharmaceutical compositions containing them, process for producing the compounds and intermediates of them
HUT64047A (en) Process for producing compounds and pharmaceutical compositions suitable for the simultaneous inhibition of no-syntase and cyclogenase
HUP0001760A3 (en) Arylacyl pyridazine derivatives, pharmaceutical compositions containing them, process for producing them and use of the compounds for producing pharmaceutical compositions
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
HUP9801532A3 (en) Use of benzimidazole derivatives for producing pharmaceutical compositions for inhibiting the growth of cancers
HUT63628A (en) Process for producing new cefalosporing derivatives and pharmaceutical compositions comprising same
HUP9600071A3 (en) Indolo-piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUT60488A (en) Process for producing pyrimidine derivatives and pharmaceutical compositions comprising same
HUT69712A (en) Process for preparing benzimidazole derivatives and pharmaceutical compositions containing them
HUT76065A (en) Indole derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9600876A3 (en) Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP0100170A3 (en) N-benzyl-3-indenylacetamides derivatives and use of them for producing pharmaceutical compositions for treating neoplasia
HUT74187A (en) 3-phenyl-izoquinolin-(2h)-one derivatives, process for producing them and use of them for producing pharmaceutical compositions
HUP0002952A3 (en) Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them
HUP9801993A3 (en) Ascomycin derivatives and their use for preparation of pharmaceutical compositions, process for their preparation and pharmaceutical compositions containing them
HUP9901190A3 (en) Sulfonamide derivatives of imidazole, process for producing them and pharmaceutical compositions containing them
HUP0000233A3 (en) Use of pyrazolinone derivatives for producing pharmaceutical compositions useful for treating disturbances of potency